DermTech, Inc. (DMTK)
Total Valuation
DermTech has a market cap or net worth of $167.97 million. The enterprise value is -$10.86 million.
Market Cap | 167.97M |
Enterprise Value | -10.86M |
Important Dates
The next earnings date is Wednesday, August 3, 2022, after market close.
Estimated Earnings Date | Aug 3, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
DermTech has 29.94 million shares outstanding. The number of shares has increased by 9.88% in one year.
Shares Outstanding | 29.94M |
Shares Change (YoY) | +9.88% |
Shares Change (QoQ) | +0.32% |
Owned by Insiders (%) | 8.24% |
Owned by Institutions (%) | 79.65% |
Float | 22.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 12.89 |
PB Ratio | 0.83 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.43, with a Debt / Equity ratio of 0.11.
Current Ratio | 14.43 |
Quick Ratio | 14.36 |
Debt / Equity | 0.11 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -39.20%, which is considered low. The company has a ROIC of -141.80%.
Return on Equity (ROE) | -39.20% |
Return on Assets (ROA) | -36.10% |
Return on Capital (ROIC) | -141.80% |
Revenue Per Employee | $51,106 |
Profits Per Employee | -$366,176 |
Employee Count | 255 |
Asset Turnover | 0.05 |
Inventory Turnover | 23.26 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.28% in the last 52 weeks. The beta is 1.40, so DermTech's price volatility has been higher than the market average.
Beta (1Y) | 1.40 |
52-Week Price Change | -86.28% |
50-Day Moving Average | 6.15 |
200-Day Moving Average | 11.49 |
Average Volume (30 Days) | 953,251 |
Short Selling Information
The latest short interest is 5.28 million, so 17.64% of the outstanding shares have been sold short.
Short Interest | 5.28M |
Short % of Shares Out | 17.64% |
Short % of Float | 23.17% |
Short Ratio (days to cover) | 4.98 |
Income Statement
In the last 12 months, DermTech had revenue of $13.03 million and -93.38 million in losses. Earnings per share was -$3.16.
Revenue | 13.03M |
Gross Profit | 916,000 |
Operating Income | -94.18M |
Net Income | -93.38M |
EBITDA | -90.47M |
EBIT | -93.38M |
Earnings Per Share (EPS) | -$3.16 |
Balance Sheet
The company has $202.13 million in cash and $23.30 million in debt, giving a net cash position of $178.83 million or $5.97 per share.
Cash & Cash Equivalents | 202.13M |
Total Debt | 23.30M |
Net Cash | 178.83M |
Net Cash Per Share | $5.97 |
Book Value | 203.48M |
Book Value Per Share | 6.80 |
Working Capital | 193.70M |
Cash Flow
In the last 12 months, operating cash flow was -$76.21 million and capital expenditures -$3.35 million, giving a free cash flow of -$79.57 million.
Operating Cash Flow | -76.21M |
Capital Expenditures | -3.35M |
Free Cash Flow | -79.57M |
FCF Per Share | n/a |
Margins
Gross margin is 7.03%, with operating and profit margins of -722.65% and -716.51%.
Gross Margin | 7.03% |
Operating Margin | -722.65% |
Pretax Margin | n/a |
Profit Margin | -716.51% |
EBITDA Margin | -694.18% |
EBIT Margin | -716.51% |
FCF Margin | -610.55% |
Dividends & Yields
DermTech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -55.59% |
FCF Yield | -47.37% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.88% |
Shareholder Yield | -9.88% |
Analyst Forecast
The average price target for DermTech is $30.26, which is 439.39% higher than the current price. The consensus rating is "Buy".
Price Target | $30.26 |
Price Target Difference | 439.39% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Stock Splits
The last stock split was on August 30, 2019. It was a reverse split with a ratio of 1:2.
Last Split Date | Aug 30, 2019 |
Split Type | Reverse |
Split Ratio | 1:2 |